From the perspectives of tumor tissue and cell lines, we simultaneously found that BIRC5 and HK2 may increase tumor malignancy with MYCN amplification, whereas GRID2 and RNASEL were antagonistic to MYCN amplification. The gene discussed is HK2; the disease is neoplasm.